New patent for Abbvie Inc’s VUITY drug – DrugPatentWatch
Annual Drug Patent Expiration for VUITY
Vuity is a drug marketed by Abbvie Inc and included in one NDA. It is available from a single supplier. There are two patents protecting this drug.
VUITY drug price trends.
This drug has twenty-four patent family members in twenty-three countries.
The generic ingredient in VUITY is pilocarpine hydrochloride. One registered supplier for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New Patent for VUITY drug Abbvie Inc